Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03859648 · ClinicalTrials.gov registry record · NA
BONEBRIDGE Bone Conduction Implant in Adults
A NA study, sponsored by Med-El Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03859648 is a NA study that was terminated before completion, run by Med-El Corporation. The registered enrollment target is 9 participants.
The verdict
NCT03859648, a NA study, was terminated before completion, sponsored by Med-El Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Approximately thirty subjects with mixed or conductive hearing loss, meeting FDA-cleared candidacy criteria for the BONEBRIDGE, will be implanted and followed for three (3) months post-activation to assess safety and effectiveness of the BONEBRIDGE implant.
Interventions
- DEVICE BONEBRIDGE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-08-26 |
| Est. Completion | 2022-11-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03859648
The ClinicalTrials.gov registry entry for NCT03859648 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Med-El Corporation, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BONEBRIDGE is the first listed.
NCT03859648 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03859648 about?
NCT03859648 is a clinical study titled "BONEBRIDGE Bone Conduction Implant in Adults". Approximately thirty subjects with mixed or conductive hearing loss, meeting FDA-cleared candidacy criteria for the BONEBRIDGE, will be implanted and followed for three (3) months post-activation to assess safety and effectiveness of the BONEBRIDGE implant.
What is the current status of trial NCT03859648?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2019-08-26. Estimated completion is 2022-11-04.
What interventions are being tested in trial NCT03859648?
The interventions under investigation include: BONEBRIDGE (DEVICE).
Who is sponsoring clinical trial NCT03859648?
This trial is sponsored by Med-El Corporation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.